Results for this period
Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | ¥334,658 million (YoY +6.9%) |
| Operating profit | ¥8,904 million |
| Ordinary income | ¥12,685 million |
| Profit attributable to owners of the parent | ¥10,658 million (YoY +99.0%) |
| Net income per share | ¥32.35 |
| Equity ratio | End of the current fiscal period 53.4 / End of previous period 54.6 |
| Total assets | ¥1,110,113 million |
| Net assets | ¥594,472 million |
| Cash flows from operating activities | ¥13,868 million |
| Cash flows from investing activities | ¥-25,704 million |
| Cash flows from financing activities | ¥1,605 million |
| Cash and cash equivalents at end of period | ¥145,832 million |
| Full-year earnings forecast | Net Sales ¥722,000 million (YoY +6.6%) / Operating profit ¥16,500 million / Ordinary income ¥21,500 million / Net income ¥16,000 million |
| Revision to Earnings Forecast | None |
| Annual Dividend Forecast | ¥40 → ¥20(-50.0%) |
| Segment revenue | Imaging ¥129,302 million, Precision Equipment ¥90,635 million, Healthcare ¥57,080 million, Industry ¥38,377 million, Digital Manufacturing ¥17,407 million |
| Segment profit | Imaging ¥8,252 million, Precision Equipment ¥7,213 million, Healthcare ¥3,945 million, Industry ¥7,578 million, Digital Manufacturing ¥-2,266 million |
| Regional sales | ¥47,903 million, ¥89,382 million, ¥55,379 million, ¥80,449 million, ¥61,544 million |
| Depreciation and amortization | ¥20,902 million (depreciation and amortization) |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | New — companies (Company name: —) / Excluded — companies (Company name: —) |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person For media and analysts |
| Issued Shares at Period-End | 333,585,686 shares |
| Treasury Shares at Period-End | 4,112,725 shares |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This earnings report does not explain the specific reasons for changes in the results for the interim period or the earnings forecasts, and refers readers to the “Notice Regarding Revisions to the Consolidated Earnings Forecasts for the Fiscal Year Ending March 2027” disclosed on 30 October and to the earnings presentation materials.